Myogenic differentiation 1 (MYOD1) (MYOD1)

Myogenic differentiation 1 (MYOD1) is a nuclear protein that acts as a master transcriptional regulator of skeletal muscle development, a process known as myogenesis (UniProt P15172). As a member of the basic helix-loop-helix (bHLH) family of myogenic regulatory factors (MRFs), it functions by forming heterodimers with E-proteins to bind specific DNA sequences called E-boxes (CANNTG) in the promoter regions of muscle-specific genes (NCBI Gene 4654). MYOD1 is essential for committing multipotent mesodermal cells to the myogenic lineage and subsequently driving their maturation into functional muscle fibers by inducing cell cycle arrest through the activation of p21 (CDKN1A). In clinical oncology, MYOD1 is a critical diagnostic biomarker, as its immunohistochemical expression is highly specific for rhabdomyosarcoma, a malignant tumor of skeletal muscle origin (PubMed 21834987). While direct pharmacological targeting of this transcription factor with small molecules is currently unavailable, MYOD1 is a primary focus in regenerative medicine for cell reprogramming and gene therapy approaches aimed at treating muscular dystrophies and muscle wasting conditions.

Other names

Myoblast determination protein 1Myogenic factor 3MYF3bHLHc1Class C basic helix-loop-helix protein 1

Acts as a transcriptional activator by binding to E-box sequences (CANNTG) as a heterodimer with E-proteins to initiate skeletal muscle-specific gene expression and induce cell cycle exit.